edgepedia

Researchers in cancer biology

360 articles

Eva Hernando

Eva Hernando, full name Eva M. Hernando-Monge, is a Spanish-born cancer biologist and tenured professor of pathology and dermatology at NYU Grossman School of Medicine who studies melanoma metastasis.

Francesca D. Ciccarelli

Francesca D. Ciccarelli is an Italian cancer genomics researcher known for the Network of Cancer Genes and head of the Centre for Cancer Evolution in London since 2023.

Frank J. Rauscher

Frank J. Rauscher is an American molecular biologist at The Wistar Institute known for defining the Fos–AP-1 DNA binding site and showing WT1 is a transcriptional repressor.

Frank McCormick

Frank McCormick, also known as Francis Patrick McCormick, is an American cancer biologist at UCSF who studies RAS proteins and founded Onyx Pharmaceuticals, which developed sorafenib.

Frank Stegmeier

Frank Stegmeier is an American cancer biologist and functional genomics expert known for the ClonTracer cellular barcoding method and oncology drug target discovery at Novartis and KSQ Therapeutics.

G. Paolo Dotto

Gian Paolo Dotto is a molecular biologist and cancer researcher at Massachusetts General Hospital and the University of Lausanne, known for work on Notch signaling and field cancerization.

Gabriele Bergers

Gabriele Bergers is a cancer biologist known for work on the angiogenic switch and tumor blood vessels, and a professor of oncology at KU Leuven since 2016.

Gail E. Sonenshein

Gail E. Sonenshein is a molecular biologist and professor at Tufts University School of Medicine who studies nuclear oncogenes in breast cancer and co-founded Adecto Pharmaceuticals in 2014 to develop ADAM8 antibody therapeutics.

Gary Thomas (cell biologist)

Gary Thomas is an American cell biologist, professor at the University of Pittsburgh and researcher at UPMC Hillman Cancer Center, known for identifying furin and the PACS proteins.

Geoffrey L. Greene

Geoffrey L. Greene, also known as Geoffrey Greene, is a University of Chicago cancer researcher who helped clone the human estrogen receptor and solved how tamoxifen blocks its action.

Geoffrey M. Cooper

Geoffrey M. Cooper (born 1948) is an American molecular biologist, Professor Emeritus at Boston University, known for discovering oncogenes in human cancers and writing The Cell: A Molecular Approach.

Geoffrey M. Wahl

Geoffrey M. Wahl, also known as Geoffrey Wahl, is an American molecular biologist and cancer researcher at the Salk Institute, known for linking p53 to genetic stability.

George A. Calin

George A. Calin is a molecular pathologist and cancer researcher at the University of Texas MD Anderson Cancer Center whose work established that microRNAs are involved in human cancer.

George C. Prendergast

George C. Prendergast is an American cancer researcher who developed IDO inhibitors and studied the Bin1 tumor suppressor gene, leading the Lankenau Institute for Medical Research since 2004.

George J. Todaro

George J. Todaro (born 1937) is an American virologist and cancer researcher who established the NIH 3T3 cell line and proposed the 1969 oncogene hypothesis at the National Cancer Institute.

George Khoury (molecular biologist)

George Khoury (1943–1987) was an American molecular biologist at the National Cancer Institute who produced the first transcription map of an animal virus and identified genetic enhancers.

Giannino Del Sal

Giannino Del Sal is an Italian molecular biologist, full professor of Applied Biology at the University of Trieste, known for cloning the growth-arrest gene gas1.

Giulio Draetta

Giulio Draetta is a molecular biologist and cancer researcher known for identifying the first mammalian cyclin-dependent kinase and serving as MD Anderson's first Chief Scientific Officer.

Glenn Merlino

Glenn Merlino is an American cancer biologist who spent 1980 to 2024 at the National Cancer Institute, building the first human-like mouse model of melanoma and studying HGF/MET signaling.

Grant A. McArthur

Grant A. McArthur is an Australian medical oncologist and melanoma researcher at the Peter MacCallum Cancer Centre who led the BRIM-3 and coBRIM trials establishing vemurafenib and cobimetinib.

H. Earl Ruley

H. Earl Ruley is a cancer researcher and Professor Emeritus of Pathology, Microbiology, and Immunology at Vanderbilt University Medical Center, known for showing how oncogenes cooperate to transform cells and for gene-trap mutagenesis.

Hani Goodarzi

Hani Goodarzi is an Iranian-American molecular and computational biologist who studies RNA regulation in cancer, a professor at UCSF since 2016 and a Core Investigator at the Arc Institute.

Hans‐Guido Wendel

Hans-Guido Wendel is a physician-scientist and cancer biologist at Memorial Sloan Kettering Cancer Center in New York, known for showing that eIF4E acts as an oncogene.

Hao Zhu

Hao Zhu is an American physician-scientist and medical oncologist who studies liver regeneration and liver cancer at UT Southwestern, where he directs the Tissue Regeneration Program.

Haojie Huang

Haojie Huang (黄浩杰) is a molecular biologist who researches prostate cancer, transcription factors, and therapy resistance. He is currently a Qiushi Chair Professor at Zhejiang University.

Harold L. Moses

Harold L. Moses is an American cancer biologist who discovered that TGF-β inhibits cell proliferation and founded and directed the Vanderbilt-Ingram Cancer Center from 1993 to 2005.

Harry Bartelink

Harry Bartelink, born 1946, is a Dutch radiation oncologist who directed radiation oncology at the Netherlands Cancer Institute in Amsterdam from 1985 to 2007 and led European breast and lung cancer trials.

Harry Rubin

Harry Rubin (1926–2020) was an American cancer biologist at UC Berkeley who developed the 1958 focus assay for Rous sarcoma virus and shared the 1964 Lasker Award.

Harry V. Gelboin

Harry V. Gelboin, born 1929, is an American cancer researcher who led the Laboratory of Molecular Carcinogenesis at the National Cancer Institute, studying benzo[a]pyrene metabolism and cytochrome P450.

Hartmut Beug

Hartmut Beug was a German cancer biologist who studied oncogene cooperation in leukemia and EMT in metastasis, a founding Senior Scientist at the IMP in Vienna from 1988.